163 related articles for article (PubMed ID: 27470335)
1. Anti-tumor activity of arjunolic acid against Ehrlich Ascites Carcinoma cells in vivo and in vitro through blocking TGF-β type 1 receptor.
Elsherbiny NM; Al-Gayyar MM
Biomed Pharmacother; 2016 Aug; 82():28-34. PubMed ID: 27470335
[TBL] [Abstract][Full Text] [Related]
2. Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model.
Elsherbiny NM; Eladl MA; Al-Gayyar MM
Cytokine; 2016 Jan; 77():26-34. PubMed ID: 26517155
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
Saraswati S; Agrawal SS; Alhaider AA
Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
[TBL] [Abstract][Full Text] [Related]
4. Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma.
El-Magd MA; Khamis A; Nasr Eldeen SK; Ibrahim WM; Salama AF
Biomed Pharmacother; 2017 Aug; 92():870-878. PubMed ID: 28599251
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
Agrawal SS; Saraswati S; Mathur R; Pandey M
Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
[TBL] [Abstract][Full Text] [Related]
6. Ganoderma lucidum total triterpenes attenuate DLA induced ascites and EAC induced solid tumours in Swiss albino mice.
Smina TP; Mathew J; Janardhanan KK
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(5):55-9. PubMed ID: 27188870
[TBL] [Abstract][Full Text] [Related]
7. Blocking TGF-β type 1 receptor partially reversed skin tissue damage in experimentally induced atopic dermatitis in mice.
Alyoussef A
Cytokine; 2018 Jun; 106():45-53. PubMed ID: 29549723
[TBL] [Abstract][Full Text] [Related]
8. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
[TBL] [Abstract][Full Text] [Related]
10. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic activities of MT81 and its structural analogue in Ehrlich ascites carcinoma-bearing Swiss Albino mice.
Choudhury SM; Gupta M; Majumder UK
Oxid Med Cell Longev; 2010; 3(1):61-70. PubMed ID: 20716929
[TBL] [Abstract][Full Text] [Related]
12. Arjunolic acid protects against DNCB-induced atopic dermatitis-like symptoms in mice by restoring a normal cytokine balance.
Alyoussef A
Eur Cytokine Netw; 2015; 26(2):38-45. PubMed ID: 26553587
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
14. Isolation, characterisation and cytotoxicity study of arjunolic acid from Terminalia arjuna.
Ramesh AS; Christopher JG; Radhika R; Setty CR; Thankamani V
Nat Prod Res; 2012; 26(16):1549-52. PubMed ID: 21732908
[TBL] [Abstract][Full Text] [Related]
15. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of arjunolic acid against cardiac toxicity induced by oral sodium nitrite: effects on cytokine balance and apoptosis.
Al-Gayyar MM; Al Youssef A; Sherif IO; Shams ME; Abbas A
Life Sci; 2014 Aug; 111(1-2):18-26. PubMed ID: 25064822
[TBL] [Abstract][Full Text] [Related]
18. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of renal protective effects of inhibiting TGF-β type I receptor in a cisplatin-induced nephrotoxicity model.
Bayomi HS; Elsherbiny NM; El-Gayar AM; Al-Gayyar MM
Eur Cytokine Netw; 2013; 24(4):139-47. PubMed ID: 24590376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
